Key News 1. The People's Bank of China: Improve the framework of a modern monetary policy with Chinese characteristics and refine the mechanism for issuing base money. 2. The National Development and Reform Commission and the National Energy Admini

2026-08-11

Key News 1. The People's Bank of China: Improve the framework of a modern monetary policy with Chinese characteristics and refine the mechanism for issuing base money. 2. The National Development and Reform Commission and the National Energy Administration: Accelerate the optimization and upgrading of the coal industry structure and promote the exit of outdated and ineffective production capacity. 3. The Ministry of Commerce: Preliminary findings indicate that imported pecans originating from Mexico and the United States are being dumped. Stock News 1. Unitree Automation: After the clawback mechanism was activated, the final online subscription rate was 0.01809759%. 2. Jiangbolong: Net profit for the first half of 2026 was RMB 10.577 billion, a year-on-year increase of 71,528.66%. 3. GigaDevice: A subsidiary invested US$100 million to subscribe to private equity fund shares. 4. Zhaojin Gold: Significant fluctuations in gold prices in the future will have a substantial impact on the company's operating performance. 5. Sources confirm that EVE Energy will raise prices for two types of batteries; industry insiders say this may affect subsequent electric vehicle pricing. 6. Aili Home Furnishings: Trading of its shares fluctuated abnormally; trading was suspended on August 11th for investigation. 7. Yisheng Bio-tech: July sales revenue of broiler chicks increased by 113% year-on-year. 8. Leadcore Technology (two consecutive daily limit-up): Its main business does not include indium phosphide substrates, and it has no revenue or profit related to indium phosphide substrates. 9. Xinlian Integrated Circuits: First-half net profit turned around to 278 million yuan, achieving a turnaround from a loss year-on-year. It has deployed technology platforms and product matrices in the fields of AI infrastructure and optical interconnects. 10. Gan & Lee Pharmaceuticals: Licensed Menarini to commercialize its bovangravitide for overweight or obesity in the EU-27 and other regions, with milestone payments up to €664 million.